• 1. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 2. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 3. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 4. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 5. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Haloquinolines

3-Bromo-2-fluoroquinoline (CAS No. 179488-06-3): A Versatile Building Block in Pharmaceutical and Material Science

3-Bromo-2-fluoroquinoline (CAS No. 179488-06-3) is a halogenated quinoline derivative that has gained significant attention in recent years due to its unique chemical properties and wide-ranging applications. As a fluorinated heterocyclic compound, it serves as a crucial intermediate in the synthesis of various pharmaceuticals, agrochemicals, and advanced materials. The presence of both bromine and fluorine substituents on the quinoline ring makes this compound particularly valuable for cross-coupling reactions and structure-activity relationship (SAR) studies in drug discovery.

The growing interest in 3-bromo-2-fluoroquinoline synthesis and its applications reflects current trends in medicinal chemistry, where researchers are increasingly focusing on fluorinated drug candidates and halogenated scaffolds. Recent studies have shown that fluorinated compounds account for nearly 30% of all newly approved small-molecule drugs, making fluorinated quinoline derivatives like 3-bromo-2-fluoroquinoline particularly valuable for pharmaceutical development. This compound's electron-withdrawing properties and enhanced metabolic stability make it an attractive building block for drug design.

From a synthetic chemistry perspective, 3-bromo-2-fluoroquinoline offers multiple advantages. The bromine substituent at the 3-position serves as an excellent handle for various palladium-catalyzed coupling reactions, including Suzuki, Stille, and Sonogashira couplings. Meanwhile, the 2-fluoro group influences the electronic properties of the quinoline system, affecting its hydrogen bonding capacity and lipophilicity. These characteristics have made this compound particularly useful in the development of kinase inhibitors, antimicrobial agents, and fluorescence probes.

The pharmaceutical applications of 3-bromo-2-fluoroquinoline are particularly noteworthy. Many researchers are investigating its potential as a precursor for anticancer compounds, as the quinoline scaffold is present in several FDA-approved oncology drugs. The compound's ability to serve as a protein-binding moiety has led to its incorporation in various targeted therapies. Additionally, its fluorine atom can significantly improve a drug candidate's bioavailability and blood-brain barrier penetration, making it valuable for CNS drug development.

In material science, 3-bromo-2-fluoroquinoline derivatives have shown promise in the development of organic electronic materials. The compound's conjugated π-system and halogen substituents make it suitable for creating organic semiconductors and light-emitting materials. Recent studies have explored its use in OLED technology and molecular sensors, where the fluorine atom's electronic effects can fine-tune material properties.

The synthesis of 3-bromo-2-fluoroquinoline typically involves halogenation reactions of appropriate quinoline precursors. Modern synthetic approaches emphasize regioselective bromination and direct fluorination methods to improve yield and purity. Recent advances in continuous flow chemistry have also been applied to the production of this compound, addressing common challenges in scale-up processes for halogenated heterocycles.

From a commercial perspective, the demand for 3-bromo-2-fluoroquinoline has been steadily increasing, particularly from contract research organizations and pharmaceutical companies engaged in drug discovery. The compound's price and availability are influenced by factors such as raw material costs, synthetic complexity, and purification requirements. Suppliers typically offer this chemical in various quantities, from milligram-scale for research purposes to kilogram quantities for industrial applications.

Quality control of 3-bromo-2-fluoroquinoline is crucial for its applications, with analytical methods including HPLC analysis, NMR spectroscopy, and mass spectrometry being commonly employed. The compound's stability under various storage conditions is another important consideration, with recommendations typically including protection from moisture and light to maintain purity over time.

Environmental and safety considerations for 3-bromo-2-fluoroquinoline follow standard laboratory protocols for handling halogenated compounds. While not classified as highly hazardous, proper personal protective equipment and ventilation are recommended during handling. The compound's ecological impact and degradation pathways are subjects of ongoing research, particularly regarding its potential persistence in the environment.

Future research directions for 3-bromo-2-fluoroquinoline include exploring novel catalytic systems for its synthesis, developing more efficient purification methods, and expanding its applications in bioconjugation chemistry. The compound's potential in PET radiopharmaceuticals (using fluorine-18) is another exciting avenue being investigated by research groups worldwide.

For researchers working with 3-bromo-2-fluoroquinoline, several key resources are available, including spectral databases for characterization, synthetic protocols in recent literature, and safety data sheets from suppliers. The compound's growing importance is reflected in the increasing number of patent applications and scientific publications referencing its use as a building block in various chemical contexts.

In conclusion, 3-bromo-2-fluoroquinoline (CAS No. 179488-06-3) represents a versatile and valuable compound in modern chemistry. Its unique combination of halogen substituents on the quinoline scaffold makes it indispensable for pharmaceutical research, material science, and chemical synthesis. As the demand for fluorinated building blocks continues to grow across multiple industries, the importance of this compound is likely to increase further in the coming years.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)